Cloxacillin Sodium EP Impurity E;18704-55-7
WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
Product Number: C120005
English Name: Cloxacillin Sodium EP Impurity E
English Alias: (2S,5R,6R)-6-((2S,5R,6R)-6-(3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
CAS Number: 18704-55-7
Molecular Formula: C27H28ClN5O7S2
Molecular Weight: 634.12
Product Advantages: Cloxacillin Sodium EP Impurity E has high purity and good chemical stability. With a clear structure and uniform properties, it remains stable under different experimental conditions and can be used as a reliable reference substance for Cloxacillin Sodium impurity analysis. Its precise characteristics can ensure the accuracy and repeatability of detection results, providing a solid basis for pharmaceutical quality research and quality control, and helping to enhance the reliability of Cloxacillin Sodium drug quality research.
Application Fields: It is mainly applied in the quality control and research and development process of Cloxacillin Sodium-related drugs. As an impurity reference standard, it is used to establish and validate the detection methods of Cloxacillin Sodium impurities, ensuring the sensitivity and specificity of detection methods. During the drug production process, it is used to monitor the content of this impurity, assist in optimizing the production process, and prevent excessive impurities from affecting drug quality. In the study of drug stability, it analyzes its changes during storage, providing important references for determining the shelf life and storage conditions of drugs.
Background Description: Cloxacillin Sodium is a commonly used β-lactam antibiotic in clinical practice for the treatment of various bacterial infectious diseases. In the process of its research, development, production and quality control, the presence of impurities may affect the safety, effectiveness and stability of the drug. As a related impurity of Cloxacillin Sodium, in-depth research on Cloxacillin Sodium EP Impurity E helps to comprehensively evaluate drug quality, ensure the safety and effectiveness of clinical medication, and reduce the risk of medication caused by impurities.
Research Status: Currently, research on Cloxacillin Sodium EP Impurity E continues to advance. In terms of detection technology, advanced technologies such as Ultra-Performance Liquid Chromatography - Mass Spectrometry (UPLC - MS) and high-resolution mass spectrometry are constantly being explored to achieve accurate detection of trace impurities. In the study of impurity generation mechanisms, the formation causes and influencing factors are deeply analyzed by simulating the drug synthesis process and storage environment, providing theoretical support for controlling impurities from the source. At the same time, research on the interaction between this impurity and Cloxacillin Sodium and its impact on drug efficacy and safety is also gradually carried out, aiming to further improve the comprehensive understanding of the quality of Cloxacillin Sodium drugs.
NOTE！
We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!
WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
NEW IN STOCK!
The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!
China
